default author photo

Olivia Rastoin

Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN)

France

SCHOLARLY PAPERS

2

DOWNLOADS

123

TOTAL CITATIONS

2

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Tumor-Induced Cholesterol Efflux from Macrophages Drives IL-4 Mediated Reprogramming and Tumor Progression

Number of pages: 40 Posted: 14 Nov 2018
Pieter Goossens, Juan Rodriguez-Vita, Anders Etzerodt, Marion Masse, Olivia Rastoin, Victoire Gouirand, Miranda Van Eck, Thomas Ulas, Olympia Papantonopoulou, Magali Bebien, Martin Turner, Thien Phong Vu Manh, Marc Dalod, Nathalie Auphan-Anezin, Joachim L. Schultze and Toby Lawrence
Aix Marseille Université - CNRS, INSERM, CIML, Aix Marseille Université - CNRS, INSERM, CIML, Aix Marseille Université - CNRS, INSERM, CIML, Aix Marseille Université - CNRS, INSERM, CIML, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Aix Marseille Université - CNRS, INSERM, CIML, Leiden University, Leiden Academic Centre for Drug Research, Division of BioTherapeutics, University of Bonn, LIMES Institute, Genomics and Immunoregulation, University of Bonn, Life and Medical Sciences Institute (LIMES), Genomics & Immunoregulation, Aix Marseille Université - CNRS, INSERM, CIML, The Babraham Institute - Laboratory of Lymphocyte Signaling and Development, Aix Marseille Université - CNRS, INSERM, CIML, Aix Marseille Université - CNRS, INSERM, CIML, Aix Marseille Université - CIML, University of Bonn - Life and Medical Sciences Institute (LIMES) and King’s College London - Centre for Inflammation Biology and Cancer Immunology
Downloads 70 (875,328)
Citation 2

Abstract:

Loading...

2.

Cabozantinib, a Promising Therapeutic Strategy for Resistant Head and Neck Squamous Cell Carcinoma Patients

Number of pages: 164 Posted: 09 Aug 2021
Anais Hagege, Olivia Rastoin, Damien Ambrosetti, Julien Boyer, Xingkang He, Julie Rousset, Christopher Montemagno, Julien Parola, Isabelle Bourget, Frederic Luciano, Esma Saada-Bouzid, Alexandre Bozec, Yihai Cao, Gilles Pagès and Maeva Dufies
Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Cote d'Azur - Central laboratory of Pathology, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Centre Antoine Lacassagne, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN) and Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN)
Downloads 53 (1,031,043)

Abstract:

Loading...

AXL, c-MET, head and neck squamous cell carcinoma (HNSCC), radiotherapy, cisplatin, resistance, cabozantinib, anti-angiogenic, VEGFR inhibitor, therapy repositioning